FindTrial
Sign In

Iron absorption from salt double fortified with iodine in iron-deficient Indian women.

Iron absorption from salt double fortified with iodine and an encapsulated ferric pyrophosphate compound: a stable isotope study in iron-deficient Indian women.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028936
Enrollment
41
Registered
2020-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Double fortified salt: Double fortified salt of varying compositions (Iodized salt + 57FePP encapsulated, Iodized salt + 57FePP + CA/TSC encapsulated, Iodized salt + 57FePP + CA/NaPP en

Sponsors

Bill and Melinda Gates Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Written informed consent Female, 18 to 40 years old SF Normal body Mass Index (18.5 â?? 25 kg/m2) Bodyweight

Exclusion criteria

Exclusion criteria: Pregnancy (assessed by self-declaration) Lactating up to 6 weeks before study initiation Anemia (Hb Elevated CRP ( >5.0 mg/L) Consumption of mineral and vitamin supplements within 2 weeks before 1st meal administration Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 4 months Earlier participation in a study using Fe stable isotopes or participation in any clinical study within the last 30 days A participant who cannot be expected to comply with the study protocol (e.g. not available on certain study appointments) Continuous/long-term use of medication during the whole study (except for contraceptives) Any metabolic, gastrointestinal kidney or chronic diseases such as diabetes, hepatitis, hypertension, cancer or cardiovascular diseases Smokers ( > 1 cigarette per week) Difficulties with blood sampling Male gender

Design outcomes

Primary

MeasureTime frame
To compare encapsulated ferrous fumarate (FeFum) with co-encapsulated FePP and with solubilizing agents.Timepoint: 2:Baseline and Endline.—

Secondary

MeasureTime frame
To compare in iron-deficient Indian women (Serum Ferritin lesser than 25ug/L) fractional iron absorption (FIA) from double fortified with iodine and different iron compounds. To determine the iron status and inflammatory markers. To evaluate the sensory properties of the different double fortified salts in local foods using triangle and acceptability tests. To determine the stability of color and iodine concentration in double fortified salt during a 6-month storage trial. Timepoint: 2:Baseline and Endline.—

Countries

India

Contacts

Public ContactDr Prashanth Thankachan

St.Johns National Academy of Health Sciences,

praxmail@gmail.com91-9886006166

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026